UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comparison of DNA and mRNA vaccines against cancer

Drug discovery today, 2020-03, Vol.25 (3), p.552-560

2020

Volltextzugriff (PDF)

CureVac COVID vaccine let-down spotlights mRNA design challenges

Nature (London), 2021-06, Vol.594 (7864), p.483-483

Dolgin, Elie

2021

Volltextzugriff (PDF)

How COVID unlocked the power of RNA vaccines

Nature (London), 2021-01, Vol.589 (7841), p.189-191

Dolgin, Elie

2021

Volltextzugriff (PDF)

Chimeric Hemagglutinin Influenza Virus Vaccine Constructs Elicit Broadly Protective Stalk-Specific Antibodies

Journal of Virology, 2013-06, Vol.87 (12), p.6542-6550

2013

Volltextzugriff (PDF)

Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates

Emerging microbes & infections, 2021, Vol.10 (1), p.629-637

2021

Volltextzugriff (PDF)

COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge

Immunity (Cambridge, Mass.), 2021-08, Vol.54 (8), p.1869-1882.e6

2021

Volltextzugriff (PDF)

Could mixing COVID vaccines boost immune response?

Nature (London), 2021-02, Vol.590 (7846), p.375-376

Ledford, Heidi

2021

Volltextzugriff (PDF)

Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study

The Lancet infectious diseases, 2017-08, Vol.17 (8), p.854-866

2017

Volltextzugriff (PDF)

High-Dose Recombinant Influenza Vaccine: NNT = 3,000 to Prevent One More Infection, No Impact on Hospitalization

American family physician, 2024-04, Vol.109 (4), p.372

Ebell, Mark H

2024

Volltextzugriff (PDF)

Central Memory CD4⁺ T Cells Are Responsible for the Recombinant Bacillus Calmette-Guérin ΔureC∷hly Vaccine's Superior Protection Against Tuberculosis

The Journal of infectious diseases, 2014-12, Vol.210 (12), p.1928-1937

2014

Volltextzugriff (PDF)

The effect of recombinant zoster vaccine on patients with chronic obstructive pulmonary diseases: A multi‐institutional propensity score‐matched cohort study

Journal of medical virology, 2024-09, Vol.96 (9), p.e29911-n/a

2024

Volltextzugriff (PDF)

Effects of age and gender on immunogenicity and reactogenicity of SpikoGen recombinant spike protein vaccine: a post-hoc analysis

Scientific reports, 2024-09, Vol.14 (1), p.22631, Article 22631

2024

Volltextzugriff (PDF)

The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease

Vaccine, 2011-09, Vol.29 (42), p.7267-7275

2011

Volltextzugriff (PDF)

Cross-Protection Conferred by Combined Vaccine Containing Infectious Bronchitis Virus Attenuated Massachusetts and Recombinant LaSota Virus Expressing Arkansas Spike

Avian diseases, 2023-09, Vol.67 (3), p.273

2023

Volltextzugriff (PDF)

Immunogenicity of a pentavalent recombinant Escherichiacoli bacterin against enterotoxemia and botulism in sheep

Anaerobe, 2024-10, Vol.89, p.102895, Article 102895

2024

Volltextzugriff (PDF)

Malaria vaccine: WHO position paper, January 2016 – Recommendations

Vaccine, 2018-06, Vol.36 (25), p.3576-3577

World Health Organization

2018

Volltextzugriff (PDF)

COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol

Allergy and asthma proceedings, 2021-11, Vol.42 (6), p.515-521

2021

Volltextzugriff (PDF)

Homologous and heterologous antigenic matched vaccines containing different H5 hemagglutinins provide variable protection of chickens from the 2014 U.S. H5N8 and H5N2 clade 2.3.4.4 highly pathogenic avian influenza viruses

Vaccine, 2017-11, Vol.35 (46), p.6345-6353

2017

Volltextzugriff (PDF)

Immunization with Recombinant Plasmodium falciparum Erythrocyte Membrane Protein 1 CIDRα1 Domains Induces Domain Subtype Inhibitory Antibodies

Infection and immunity, 2018-11, Vol.86 (11)

2018

Volltextzugriff (PDF)

Protection of White Leghorn chickens by U.S. emergency H5 vaccination against clade 2.3.4.4 H5N2 high pathogenicity avian influenza virus

Vaccine, 2017-11, Vol.35 (46), p.6336-6344

2017

Volltextzugriff (PDF)

A therapeutic vaccine for nicotine dependence: preclinical efficacy, and phase I safety and immunogenicity

European journal of immunology, 2005-07, Vol.35 (7), p.2031-2040

2005

Volltextzugriff (PDF)

mRNA Vaccination: An Outlook on Innate Sensing and Adaptive Immune Responses

Viruses, 2024-09, Vol.16 (9), p.1404

2024

Volltextzugriff (PDF)

Tissue-Resident Memory T Cells in the Lungs Protect against Acute Respiratory Syncytial Virus Infection

ImmunoHorizons, 2021-02, Vol.5 (2), p.59-69

2021

Volltextzugriff (PDF)

1 – 25 von 644

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(500)
Mit Volltextzugriff
(352)

Publikationsform

Sprache

14 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Vaccines, Synthetic - Administration & Dosage
(505)
Humans
(434)
Vaccines, Synthetic - Immunology
(376)
Animals
(339)
Female
(251)
Male
(180)
Mice
(166)
Adult
(143)
Biological And Medical Sciences
(127)
Vaccination
(116)
Hepatitis B - Prevention & Control
(112)
Hepatitis B Vaccines - Administration & Dosage
(100)
Middle Aged
(85)
Immunization Schedule
(84)
Vaccines, Synthetic - Adverse Effects
(84)
Mice, Inbred Balb C
(83)
Adolescent
(81)
Vaccines, Synthetic - Genetics
(79)
Vaccines
(75)
Immunization
(73)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Comparison of DNA and mRNA vaccines against cancer

CureVac COVID vaccine let-down spotlights mRNA design challenges

How COVID unlocked the power of RNA vaccines

Chimeric Hemagglutinin Influenza Virus Vaccine Constructs Elicit Broadly Protective Stalk-Specific Antibodies

Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates

COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge

Could mixing COVID vaccines boost immune response?

Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study

Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP

High-Dose Recombinant Influenza Vaccine: NNT = 3,000 to Prevent One More Infection, No Impact on Hospitalization

Central Memory CD4⁺ T Cells Are Responsible for the Recombinant Bacillus Calmette-Guérin ΔureC∷hly Vaccine's Superior Protection Against Tuberculosis

The effect of recombinant zoster vaccine on patients with chronic obstructive pulmonary diseases: A multi‐institutional propensity score‐matched cohort study

Effects of age and gender on immunogenicity and reactogenicity of SpikoGen recombinant spike protein vaccine: a post-hoc analysis

The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease

Cross-Protection Conferred by Combined Vaccine Containing Infectious Bronchitis Virus Attenuated Massachusetts and Recombinant LaSota Virus Expressing Arkansas Spike

Immunogenicity of a pentavalent recombinant Escherichiacoli bacterin against enterotoxemia and botulism in sheep

Malaria vaccine: WHO position paper, January 2016 – Recommendations

COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol

Homologous and heterologous antigenic matched vaccines containing different H5 hemagglutinins provide variable protection of chickens from the 2014 U.S. H5N8 and H5N2 clade 2.3.4.4 highly pathogenic avian influenza viruses

Immunization with Recombinant Plasmodium falciparum Erythrocyte Membrane Protein 1 CIDRα1 Domains Induces Domain Subtype Inhibitory Antibodies

Protection of White Leghorn chickens by U.S. emergency H5 vaccination against clade 2.3.4.4 H5N2 high pathogenicity avian influenza virus

A therapeutic vaccine for nicotine dependence: preclinical efficacy, and phase I safety and immunogenicity

mRNA Vaccination: An Outlook on Innate Sensing and Adaptive Immune Responses

Tissue-Resident Memory T Cells in the Lungs Protect against Acute Respiratory Syncytial Virus Infection

Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02)

Aktive Filter

Suchergebnisse filtern